Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report)’s stock price dropped 5.7% during mid-day trading on Monday after Truist Financial lowered their price target on the stock from $10.00 to $8.00. Truist Financial currently has a hold rating on the stock. Pediatrix Medical Group traded as low as $6.96 and last traded at $6.98. Approximately 507,044 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 996,439 shares. The stock had previously closed at $7.40.
Several other research analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 price target on the stock in a research note on Friday, June 7th. StockNews.com raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research report on Wednesday, July 10th. Six analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $8.70.
View Our Latest Stock Report on Pediatrix Medical Group
Hedge Funds Weigh In On Pediatrix Medical Group
Pediatrix Medical Group Trading Down 5.7 %
The company has a market cap of $587.37 million, a P/E ratio of -8.56, a price-to-earnings-growth ratio of 1.47 and a beta of 1.56. The firm has a 50-day moving average of $7.53 and a 200 day moving average of $8.67. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.81.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.15 by $0.02. Pediatrix Medical Group had a negative net margin of 3.53% and a positive return on equity of 10.31%. The company had revenue of $495.10 million during the quarter, compared to the consensus estimate of $496.25 million. On average, analysts predict that Pediatrix Medical Group, Inc. will post 1.13 earnings per share for the current fiscal year.
About Pediatrix Medical Group
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Further Reading
- Five stocks we like better than Pediatrix Medical Group
- How to Invest in the Best Canadian Stocks
- Automaker’s Bold Move to an EV Future: Is It Time to Buy Stock?
- How to Calculate Stock Profit
- Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks
- Upcoming IPO Stock Lockup Period, Explained
- Major Gaming Stock to Watch: Why It’s a Safe Bet Now
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.